DABRAFENIB
dabrafenib 50 mg capsule, 120
DABRAFENIB (2954L)
2954L
Manner of administration:Oral
Restriction 17949
Indication: Unresectable Stage III or Stage IV malignant melanoma
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 120 | # of repeats: 5 | DPMQ: $4,799.35 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Tafinlar | |||||